Relationship of Copeptin, a Surrogate Marker for Arginine Vasopressin, With Change in Total Kidney Volume and GFR Decline in Autosomal Dominant Polycystic Kidney Disease: Results From the CRISP Cohort

American Journal of Kidney Diseases - United Kingdom
doi 10.1053/j.ajkd.2012.08.038
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Elsevier BV

Related search

Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease

Canadian Journal of Kidney Health and Disease
Nephrology
2017English

Kidney Volume and Function in Autosomal Dominant Polycystic Kidney Disease

Clinical and Experimental Nephrology
PhysiologyNephrology
2013English

Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease

New England Journal of Medicine
Medicine
2010English

Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

Kidney International Reports
Nephrology
2017English

Development of a Rapid Semi-Automated Tool to Measure Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease

The Lancet
Medicine
2017English

TRPP2 and Autosomal Dominant Polycystic Kidney Disease

Biochimica et Biophysica Acta - Molecular Basis of Disease
Molecular MedicineMolecular Biology
2007English

Recent Advances in Autosomal-Dominant Polycystic Kidney Disease

Internal Medicine Journal
Internal Medicine
2016English

Seminal Vesicles in Autosomal Dominant Polycystic Kidney Disease

2015English

Intracranial Cysts in Autosomal Dominant Polycystic Kidney Disease

Journal of Neurosurgery
SurgeryNeurology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy